Stock search

Ticker or company name

Thermo Fisher Scientific

TMO · NYSE · Life Sciences Tools & Services

$691,33Down −8,89 (−1,27%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$257 bn
Div. yield
0,3%
Year to date
+20,8%
52 weeks: $435,27$727,56

Ratio score

56/100
Ratio would watch

based on 8 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

3 ✓ · 3 — · 2 ✕ · 2 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM36,331,837,9
Forward P/E25,5—29,5
PEG3,8—3,7
P/S5,44,86,6
EV/EBITDA29,527,329,9
P/FCF33,8—38,7
P/B4,74,55,4

Industry median — across 11 profitable companies in “Life Sciences Tools & Services” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 34 analysts

Buy
27
Hold
7
Sell
0

Beat the EPS forecast in 4 of the last 4 quarters

QuarterEstimateActualSurprise
Q3 20266,476,68Up +3,3%
Q2 20265,776,03Up +4,5%
Q1 20265,295,44Up +2,8%
Q4 20256,516,57Up +0,9%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Revenue12,1 bn12,0 bn11,0 bn12,2 bn11,1 bn10,9 bn10,4 bn11,4 bn10,6 bn10,5 bn10,3 bn10,9 bn
EPS4,644,684,435,214,274,283,984,784,254,043,464,20
Margin14,2%14,5%15,0%16,1%14,5%14,9%14,5%16,1%15,4%14,7%——
FCF2,11 bn1,68 bn816 m2,99 bn1,84 bn1,11 bn361 m2,81 bn1,89 bn1,66 bn904 m3,32 bn

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: no purchases, sales $135 m.

NameAmountSharesPrice
britt lisa p.28 Oct 2026 · sale$2,00 m2 831$706,45
pettiti gianluca31 Aug 2026 · sale$2,29 m3 733$614,38
pettiti gianluca31 Aug 2026 · sale$245 752400$614,38
casper marc n24 Aug 2026 · sale$38 98262$628,74
casper marc n24 Aug 2026 · sale$49 61379$628,01
casper marc n24 Aug 2026 · sale$20 67733$626,59
casper marc n24 Aug 2026 · sale$63 166101$625,41
casper marc n21 Aug 2026 · sale$201 941321$629,10
casper marc n21 Aug 2026 · sale$1,35 m2 147$628,61
casper marc n21 Aug 2026 · sale$1,12 m1 791$627,39
casper marc n21 Aug 2026 · sale$1,89 m3 014$626,51
casper marc n21 Aug 2026 · sale$1,71 m2 727$625,46
casper marc n20 Aug 2026 · sale$50 71980$633,99
casper marc n20 Aug 2026 · sale$354 446560$632,94
casper marc n20 Aug 2026 · sale$903 7741 430$632,01

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Life Sciences Tools & Services
Exchange
NYSE
Country
US
IPO date
27 Aug 1980

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
DHRDanaher Corporation$229,9161would watch37,9+5,5%16,9%
AAgilent Technologies$172,9278would consider34,1+8,6%19,5%
WATWaters Corporation$453,4229would not consider269,0—1,8%
IQVIQVIA$264,7372would consider31,3+8,8%8,1%
MTDMettler Toledo$1 727,2663would watch36,5+6,5%22,2%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.